Company · CIK 0001661998 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Q32 Bio Inc. · QTTB
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2026 SForm 4 → | Aug 27, 4:10 pm EDT | Jodie Pope MorrisonCEO, Director | 9,845 | $16.56 | $163,033 | 343,259 | −2.79% | |
| Aug 25, 2026 SForm 4 → | Aug 27, 4:10 pm EDT | Lee KalowskiCFO and President | 3,972 | $16.56 | $65,776 | 138,471 | −2.79% | |
| Aug 25, 2026 SForm 4 → | Aug 27, 4:10 pm EDT | Shelia M. VioletteChief Scientific Officer | 2,798 | $16.56 | $46,335 | 127,771 | −2.14% | |
| Jul 16, 2026 AForm 4 → | Jul 20, 9:31 pm EDT | Shelia M. VioletteChief Scientific Officer | 37,500 | — | — | 130,569 | — | |
| Jul 16, 2026 AForm 4 → | Jul 20, 9:27 pm EDT | Jodie Pope MorrisonCEO, Director | 132,000 | — | — | 353,104 | — | |
| Jul 16, 2026 AForm 4 → | Jul 20, 9:25 pm EDT | Lee KalowskiCFO and President | 53,250 | — | — | 142,443 | — | |
| Jun 30, 2026 MForm 4 → | Jul 2, 4:30 pm EDT | Isaac MankeDirector | 53,521 | $2.80 | $149,859 | 53,521 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 MForm 4 → | Jul 2, 4:30 pm EDT | Isaac MankeDirector | 53,521 | — | — | 0 | — |